24HourWire

24HourWire

News from all angles

CNBC Center

Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy

The telehealth company will now offer compounded forms of sermorelin, glutathione, NAD+, vitamin B-12 and L-carnitine, none of which are approved by the FDA.

Redirecting to CNBC in 3 seconds...

Read Now → Explore 24HourWire

Share this story with your network